| Medicamen Biotech Limited will hold a board meeting on Friday, August 14, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026, the draft annual report for the financial year 2025-26, and the draft cost audit report for the financial year 2025-26. The trading window for designated persons of the company has been closed since July 1, 2026, and will reopen 48 hours after the financial results are declared to stock exchanges. |